GEP-NET Treatment | LUTATHERA® (lutetium Lu 177 dotatate)

Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 _^AM – 8:00 _^PM ET, excluding holidays.

An older woman stands in a white room, smiling into the distance. She has her hand raised in a high-five, and many hands reach out from the side to return the high-five. The headline next to her says: YOU GOT THIS 20,000+ patients chose LUTATHERA for the opportunity to delay NET progression––join in their strength The footnote next to her reads: Actor portrayal.

LUTATHERA has helped treat over 20,000 patients with NETs, including those:

Who have just been diagnosed with faster-growing NETs (Ki-67, 10%–55% [grade 2 or 3]) and are ready for their first treatment
Who added LUTATHERA to their treatment after progressing on SSAs

LUTATHERA can help slow down NET progression for longer.

Choosing the right first treatment for you is a big step after diagnosis. You and your doctor can decide if LUTATHERA is the right first step to slow NET progression.

See proven results with LUTATHERA

Acting early to slow NETs is an important first step

See why >

NET, neuroendocrine tumor; SSAs, somatostatin analogues.

LUTATHERA has helped treat over 20,000 patients with NETs, including those:

LUTATHERA can help slow down NET progression for longer.

Acting early to slow NETs is an important first step

Important Safety Information

Approved Use